Royal Bank of Canada Reiterates “Sector Perform” Rating for Moderna (NASDAQ:MRNA)
Moderna (NASDAQ:MRNA – Get Free Report)‘s stock had its “sector perform” rating reaffirmed by stock analysts at Royal Bank of Canada in a research report issued on Tuesday,Benzinga reports. They currently have a $40.00 price target on the stock. Royal Bank of Canada’s target price would suggest a potential upside of 11.42% from the company’s […]
Moderna (NASDAQ:MRNA – Get Free Report)‘s stock had its “sector perform” rating reaffirmed by stock analysts at Royal Bank of Canada in a research report issued on Tuesday,Benzinga reports. They currently have a $40.00 price target on the stock. Royal Bank of Canada’s target price would suggest a potential upside of 11.42% from the company’s […]
